Literature DB >> 21471742

Measles outbreak in adults in Italy.

Matteo Bassetti1, Eva Schenone, Anna Calzi, Marco Camera, Laura Valle, Filippo Ansaldi, Gabriella Pagano, Claudio Viscoli.   

Abstract

Several outbreaks of measles have been reported since 2007 both in Italy and elsewhere in Europe. The objective of this study was to analyze the characteristics of the cases of measles that were hospitalized at San Martino Hospital from January 2008 to April 2009. All suspected cases of measles from January 2008 to April 2009 were analyzed. Laboratory confirmation was attained by determination of measles-specific IgM antibodies with enzyme immunoassay and/or detection of the measles virus genome in throat swab or urine by nested polymerase chain reaction (PCR). In all, 114 patients with clinically suspected measles were observed and laboratory confirmation was obtained in 83 cases: 34 (34/83; 41%) by specific genome PCR; five (5/83; 6%) only by IgM antibodies and 44 (44/83; 53%) by both methods. The median age was 25 years (range 15-66). The vaccination status was known for 80/83 patients, amongst whom the proportion of unvaccinated was 90% (72/80). No severe complications were observed. The most common complications were nausea/vomiting in 28/83 (34%) and radiologically documented interstitial pneumonia in 22/83 (26%) cases. The median length of hospitalization was five days (range 1-9 days). Almost 90% of patients were aged 20 years and older and hence measles cannot be regarded solely as a childhood disease. Thus widespread high vaccination coverage would be required to prevent new outbreaks and hospitalizations in the adult population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21471742

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  8 in total

1.  Implication of health care personnel in measles transmission.

Authors:  Núria Torner; Ruben Solano; Cristina Rius; Angela Domínguez; The Measles Elimination Program Surveillance Network Of Catalonia Spain
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

2.  Measles in adults during an outbreak in Spain: hospitalization associated with gastrointestinal and liver involvement.

Authors:  Esperanza Merino; José M Ramos; Sergio Reus; Vicente Boix; Alina Zurita; Elizabeth Alzate; Carmen Giner; Joaquín Portilla
Journal:  Infection       Date:  2014-06-25       Impact factor: 3.553

3.  Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.

Authors:  Núria Torner; Andres Anton; Irene Barrabeig; Sara Lafuente; Ignasi Parron; César Arias; Neus Camps; Josep Costa; Ana Martínez; Roser Torra; Pere Godoy; Sofia Minguell; Glòria Ferrús; Carmen Cabezas; Ángela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

4.  Measles outbreak from February to August 2017 in Messina, Italy.

Authors:  M A Palamara; G Visalli; I Picerno; A DI Pietro; G Puglisi; F Marano; G D'Andrea; A FACCIOLà
Journal:  J Prev Med Hyg       Date:  2018-03-30

5.  Analysis of measles-related hospitalizations in Tuscany from 2000 to 2014.

Authors:  E Berti; S Sollai; E Orlandini; L Galli; M DE Martino; E Chiappini
Journal:  Epidemiol Infect       Date:  2016-05-31       Impact factor: 4.434

6.  Pulmonary measles disease: old and new imaging tools.

Authors:  Fabrizio Albarello; Massimo Cristofaro; Elisa Busi Rizzi; Maria Letizia Giancola; Emanuele Nicastri; Vincenzo Schininà
Journal:  Radiol Med       Date:  2018-07-30       Impact factor: 6.313

Review 7.  Hospital preparedness in community measles outbreaks-challenges and recommendations for low-resource settings.

Authors:  Sadia Shakoor; Fatima Mir; Anita K M Zaidi; Afia Zafar
Journal:  Emerg Health Threats J       Date:  2015-04-15

Review 8.  Adverse events of vaccines and the consequences of non-vaccination: a critical review.

Authors:  Luana Raposo de Melo Moraes Aps; Marco Aurélio Floriano Piantola; Sara Araujo Pereira; Julia Tavares de Castro; Fernanda Ayane de Oliveira Santos; Luís Carlos de Souza Ferreira
Journal:  Rev Saude Publica       Date:  2018-04-12       Impact factor: 2.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.